WASABI METHOD / PROFESSIONAL RESOURCES
Massage Therapy Shockwave Applications
Understand the evidence. Connect treatment with purposeful care.
Acoustic wave therapy for massage professionals brings questions about muscle pain, recovery, device selection and professional responsibility into the same conversation. This resource helps massage therapists and multidisciplinary teams explore where shockwave research may inform complementary care, and where medical assessment or specialist management comes first.
Compare applications involving myofascial pain, trigger points, carpal tunnel symptoms, spasticity and emerging neurological uses. Wasabi Method takes an evidence-informed, manufacturer-neutral approach, separating clinical findings from proposed mechanisms and commercial terminology.
Author: Wasabi Method | SWSNA
Medical reviewer: Adam Gavine, BHK, M.Chiro | Shockwave Trainer | International Medical Shockwave Advisor
Medical review date: 10/2026
Explore professional shockwave training · Read the shockwave contraindications resource
Understanding Shockwave and Pressure Wave Therapy
Extracorporeal shockwave therapy delivers acoustic pulses from outside the body. Focused generators concentrate energy within a defined region. Radial pressure-wave systems produce a different pressure field, spreading outward from the applicator. Their greatest pressure is near the application surface. These differences matter when selecting a device and interpreting published treatment settings.[2]
Radial pressure waves are relevant to superficial soft-tissue practice, but the research does not establish one technology as a universal gold standard for massage therapy. Device selection should follow the clinical question, target depth, evidence, device instructions and the practitioner's authorised role. Evidence from a physician-led rehabilitation service does not automatically establish the same outcomes in a massage practice.[1][2]
A complementary or holistic approach can consider comfort, activity, sleep and recovery alongside physical findings. Calling a service elective, wellness-based or CAM does not resolve an unexplained symptom or extend professional scope. Arrange appropriate assessment when diagnosis falls outside your qualifications; establish whether a proposed device and application are permitted before offering treatment.
Terminology at a Glance
| Term | Meaning on this page |
|---|---|
| Focused ESWT | Acoustic shockwaves produced by a focused generator. The treatment field, focal depth and applicator characteristics are device dependent. |
| Radial pressure-wave therapy | Ballistic pressure-wave treatment, commonly marketed as radial shockwave therapy. It is physically distinct from focused ESWT. |
| AWT | Acoustic wave therapy: a broad commercial term that does not identify a particular generator or dose. |
| EPAT | Extracorporeal pulse activation therapy: terminology used for certain pressure-wave systems. Confirm the actual device. |
| Wave therapy / sound wave therapy | Nonspecific descriptions. Identify the technology before applying research findings. |
| Therapeutic ultrasound / vibration therapy | Different modalities. Neither term should be used as a technical synonym for ESWT or radial pressure waves. |
| Bar, Hz and mJ/mm² | Respectively, a device pressure setting, pulse repetition rate and energy flux density. They describe different quantities; bar cannot be directly converted into mJ/mm² across technologies. |
| Myofascial pain / spasticity | Myofascial pain involves a regional muscle pain presentation; spasticity is associated with a neurological disorder. Ordinary muscle tightness is not sufficient to diagnose spasticity. |
Professional Scope Before Device Selection
Before integrating radial pressure waves in massage practice, check the rules of the relevant licensing authority, the device's instructions and intended use, insurance requirements and any referral or supervision conditions. A course certificate documents education; confirm separately what your professional authorisation permits.
The ISMST recommendations describe medical assessment and trained professional delivery. They do not constitute a blanket endorsement of shockwave treatment by massage therapists.[1] This page reviews research relevant to collaborative care; it does not establish massage-specific efficacy or authority to diagnose neurological, rheumatological or dental disease.
Explore Massage and Complementary Care Applications
Select an application to review its context, research and practical limits.
- SpasticityApproved standard indication
- Myofascial relaxation*Common empirically-tested clinical use
- Mild to moderate carpal tunnel syndrome*Common empirically-tested clinical use
- Peripheral neuropathy**Exceptional / expert indication; limited mapping to polyneuropathy
- Fibromyalgia***Experimental indication; editorial classification
- TMJ / temporomandibular disorders**Exceptional / expert indication; editorial classification
- Muscle recovery after exercise*Common empirically-tested clinical use; editorial classification
- Trigger point therapy*Common empirically-tested clinical use; editorial mapping
- Regional pain relief*Common empirically-tested clinical use; editorial description of selected musculoskeletal care
- Neuromuscular dysfunction***Experimental indication; editorial classification of this broad category
Where the Labels Come From
This page uses the ISMST recommendations page, whose indications statement is headed October 12, 2016, and distinguishes its explicit listings from Wasabi Method's editorial mappings.[1]
| Application group | Classification basis |
|---|---|
| Spasticity; myofascial syndrome; mild to moderate carpal tunnel syndrome | Explicit ISMST entries. “Myofascial relaxation” and trigger point care are mapped to the syndrome rather than presented as separate official listings. |
| Peripheral neuropathy | The explicit expert entry is polyneuropathy. The broader label on this page must not be extended to every nerve disorder. |
| Fibromyalgia; TMJ disorders; exercise recovery; general regional pain; broad neuromuscular dysfunction | Editorial categories for this resource, not verbatim ISMST indications. Their labels describe this page's educational framework. |
| Complex regional pain syndrome | Explicitly experimental in ISMST guidance. It is distinct from the general goal of reducing regional musculoskeletal pain. |
Professional classification, research certainty and regulatory status answer different questions. A promising trial does not automatically change any of the other categories.
Spasticity
Approved Standard Indication
Overview
Spasticity can follow conditions such as stroke or cerebral palsy. Treatment objectives may include easier movement, positioning, hygiene or care, rather than simply making a muscle feel softer. Confirm the neurological diagnosis and work within a rehabilitation plan; new or unexplained abnormal tone requires assessment.
Anatomy and Treatment Targeting
Assessment identifies the involved muscle groups and distinguishes dynamic tone from fixed contracture, pain-related guarding and joint restriction. Consider nearby nerves, vessels and vulnerable skin. A neurological diagnosis does not make every tight muscle an appropriate treatment target.
Illustrative Protocol Framework
Reference 3 provides a route to the individual trials. A reproducible framework must identify the generator, applicator, treated muscles, dose units, impulses per muscle, Hz, treatment intervals and follow-up. No pooled protocol is prescribed here: a review covering several devices does not supply interchangeable settings.
Technique and Care Integration
Support the limb comfortably, establish communication and use coupling according to the device instructions. Coordinate with rehabilitation clinicians managing positioning, exercise, orthoses and prescribed treatments. Delivery requires competence in neurological presentations and anatomy, in addition to device operation.
Course of Care and Reassessment
Document a functional goal and an appropriate tone measure used by a qualified examiner. Review tolerance at every visit and function at a predefined checkpoint. Stop or refer for new weakness, neurological change, injury or deterioration; a temporary tone change alone is insufficient reason to continue indefinitely.
Safety and Further Education
Impaired sensation or communication can obscure adverse responses. Review shockwave contraindications and professional education.
Myofascial Relaxation*
Common Empirically-Tested Clinical Use
Overview
Here, myofascial relaxation describes a care objective for assessed muscle pain and movement restriction. It is not a claim that acoustic pulses permanently release fascia or break adhesions. Consider loading, activity, sleep, stress and relevant medical contributors alongside local tenderness.
Anatomy and Treatment Targeting
Identify the symptomatic muscle and its relationship to nearby nerves, vessels, joints and the chest wall. Assessment may include symptom history, movement and palpation. Tenderness alone cannot exclude referred pain, radiculopathy or other disease.
Illustrative Protocol Framework
The active arm in reference 4 reported 0.056 mJ/mm², 1,000 impulses per session and four sessions over two weeks. The control used 0.001 mJ/mm².[4] These are research identifiers, not a complete prescription. Verify the original generator, applicator, repetition rate and delivery method in the full methods before discussing clinical transfer; missing details are not inferred here.
Technique and Care Integration
Use supported positioning, suitable coupling and stable applicator contact in line with the instructions. Integrate any intervention with agreed manual therapy, movement and self-management goals. Avoid using tolerance alone to determine dose or escalating exposure to chase tenderness.
Course of Care and Reassessment
Record pain during a meaningful activity, relevant range of motion and the patient's goal. Reassess after an agreed, finite course. Continue only when progress and tolerance justify it; persistent or spreading symptoms warrant renewed assessment.
Safety and Further Education
Use particular caution around the neck, thorax and superficial neurovascular structures. Read the full safety resource and explore clinical reasoning training.
Mild to Moderate Carpal Tunnel Syndrome*
Common Empirically-Tested Clinical Use
Overview
Carpal tunnel syndrome involves median nerve compression at the wrist. Confirm the diagnosis and severity before discussing adjunctive treatment. Numbness can originate elsewhere, and progressive weakness or muscle wasting requires timely medical assessment.
Anatomy and Treatment Targeting
The median nerve passes through the carpal tunnel with the flexor tendons beneath the transverse carpal ligament. Clinical assessment, and electrodiagnostic testing or ultrasound when indicated, support selection. Avoid treating the entire forearm as though every sensory symptom originates at the wrist.
Illustrative Protocol Framework
The study identifies a Physio Shock Wave Therapy system from Pagani Elettronica and ultrasound localisation of the median nerve at the proximal tunnel.[5] Use the full methods for applicator details, pressure, impulses, Hz, single-versus-repeated session allocation and concurrent splint use. This page does not supply a partial wrist-treatment dose.
Technique and Care Integration
Position the forearm and wrist comfortably and follow the source method and device instructions for coupling and contact. Coordinate with the clinician overseeing splinting, activity adjustments and other indicated care. Ultrasound-guided identification requires appropriate training and authority.
Course of Care and Reassessment
Track night symptoms, hand function, sensory change and, when appropriate, Boston Carpal Tunnel Questionnaire scores. Arrange a defined review point. Worsening numbness, grip loss or thenar weakness calls for reassessment rather than automatically adding sessions.
Safety and Further Education
Reduced sensation makes discomfort an unreliable safety guide. Read contraindications and precautions and professional training options.
Peripheral Neuropathy**
Exceptional / Expert Indication
Overview
Peripheral neuropathy is a broad category, including metabolic, toxic, compressive and other nerve disorders. Establish the cause and distinguish local entrapment from polyneuropathy. The expert classification on this page maps specifically to the ISMST polyneuropathy listing, not every presentation of tingling or burning.
Anatomy and Treatment Targeting
Assess symptom distribution, skin integrity, sensation, circulation and functional impact through appropriately qualified care. A distal sensory symptom does not prove that the symptomatic skin is the relevant treatment target.
Illustrative Protocol Framework
Use the diagnosis-specific trials within reference 6 to identify the device, applicator, nerve region, energy or pressure units, pulse count, Hz and session schedule. No cross-condition average dose is recommended, and an entrapment-neuropathy protocol should not be relabelled as a general nerve-repair protocol.
Technique and Care Integration
Prioritise management of the cause, skin protection and appropriate medical and rehabilitation care. Check the treatment area during delivery; do not rely solely on a patient's ability to feel excessive exposure. Delivery requires competence in sensory impairment and referral pathways.
Course of Care and Reassessment
Document symptoms, function and clinically appropriate sensory measures. Agree review timing before treatment. Stop and refer for progressive deficit, new weakness, ulceration, unexplained asymmetry or deterioration.
Safety and Further Education
Assess impaired circulation and skin injury before elective treatment. Review the safety resource and education catalogue.
Fibromyalgia***
Experimental Indication
Overview
Fibromyalgia involves widespread pain with symptoms that can include fatigue, disturbed sleep and cognitive difficulty. It should not be reduced to a collection of local trigger points. Local symptom care belongs within a broader, individually paced plan following appropriate diagnostic assessment.
Anatomy and Treatment Targeting
There is no single anatomical lesion established by the diagnosis. Identify the purpose of treating a specific area and screen for other causes of focal symptoms. Widespread tenderness does not justify whole-body exposure.
Illustrative Protocol Framework
The abstract reports five weekly treatments to the three most painful areas: 500 shocks at 1.5 bar and 15 Hz, 1,000 at 2 bar and 8 Hz, then 500 at 1.5 bar and 15 Hz.[7] Verify the full paper for the device, applicator and allocation across sites before interpreting these settings. This is a study summary, not a recommended dose.
Technique and Care Integration
Use comfortable positioning and device-appropriate coupling. Coordinate with established pain care, paced activity and sleep support. Clinical competence includes recognising a symptom flare and adapting or stopping care; stronger stimulation is not inherently better.
Course of Care and Reassessment
Track pain interference, activity, fatigue, sleep and a consistent validated measure such as the Revised Fibromyalgia Impact Questionnaire. Agree a short review period and evaluate delayed responses. Stop if flares persist or function worsens.
Safety and Further Education
New focal neurological signs or systemic symptoms require assessment. Read shockwave precautions and explore professional learning.
TMJ / Temporomandibular Disorders**
Exceptional / Expert Indication
Overview
TMJ names the joint; temporomandibular disorders describe a group of muscle and joint conditions. Distinguish myogenous jaw pain from joint locking, inflammatory disease, dental pathology and trauma. The expert label here is editorial and is not an ISMST endorsement of all jaw treatment.
Anatomy and Treatment Targeting
Relevant anatomy includes the masseter, temporalis, joint capsule and nearby facial structures. Dental or orofacial assessment should identify the pain presentation and appropriate target. The eyes, ears, superficial nerves and vulnerable cranial structures require particular care.
Illustrative Protocol Framework
Consult the original trials within reference 8 for device and applicator, extraoral or other approach, target, energy or pressure, impulses, Hz and scheduling. No universal facial settings or intraoral technique is proposed here.
Technique and Care Integration
Coordinate with dental or orofacial pain care, education and appropriate rehabilitation. Position the head comfortably and use only an authorised, device-supported method. Competence in facial anatomy and recognition of dental disease is essential.
Course of Care and Reassessment
Track pain with chewing, mouth opening using a consistent method and patient-reported function. Reassess at a predefined interval. Refer locking, trauma, swelling, progressive limitation or unexplained facial pain.
Safety and Further Education
Do not extrapolate treatment across the skull or near the eyes. Read the full contraindications resource and review training prerequisites.
Muscle Recovery After Exercise*
Common Empirically-Tested Clinical Use
Overview
Delayed-onset muscle soreness follows certain unfamiliar or strenuous exercise exposures. It differs from an acute tear, compartment syndrome or rhabdomyolysis. Treatment goals may concern soreness and return to normal activity; symptom relief is not proof of accelerated tissue repair.
Anatomy and Treatment Targeting
Identify the exercised muscle, symptom onset and functional effect. Examine unexpected swelling, bruising or weakness before choosing a treatment area. Avoid treating presumed soreness over a suspected acute injury.
Illustrative Protocol Framework
The trial abstract reports one treatment, 0.06–0.09 mJ/mm² and 200 pulses at each of seven biceps points.[9] Confirm the generator, applicator, Hz, timing after exercise and complete methods in the original paper. These values should not be converted into a radial bar setting or repeated as an untested course.
Technique and Care Integration
Support the limb and follow device-specific coupling and contact guidance. Integrate any intervention with load adjustment, sleep and appropriate nutrition and recovery planning. Delivery requires competence in differentiating soreness from injury and in escalation pathways.
Course of Care and Reassessment
Record soreness, movement and a relevant functional task; review during the expected short recovery period. Avoid attributing natural recovery entirely to treatment. Refer severe weakness, disproportionate pain, marked swelling or dark urine for medical assessment.
Safety and Further Education
Do not use pain reduction alone to clear an athlete for unrestricted activity. Review safety guidance and professional education.
Trigger Point Therapy*
Common Empirically-Tested Clinical Use
Overview
Trigger point care addresses a local or referred myofascial pain presentation identified through assessment. It overlaps with myofascial relaxation but should have a defined objective, such as more comfortable movement, rather than a promise to eliminate every tender point.
Anatomy and Treatment Targeting
Document the involved muscle, symptom reproduction and surrounding anatomy. Palpation has limitations and should be interpreted alongside history and movement. Distinguish muscular symptoms from neurological or joint-related pain.
Illustrative Protocol Framework
Reference 4 is an illustrative myofascial source, not a universal trigger point prescription. Identify generator, applicator, pulse allocation per site, energy units, Hz, spacing of sessions and outcome timing. Do not multiply exposure by treating an unrestricted number of tender sites.
Technique and Care Integration
Use supported positioning and device-compatible coupling. Integrate care with manual techniques, relevant movement and load management. The practitioner must recognise neurovascular anatomy and understand how to modify or stop delivery when symptoms change.
Course of Care and Reassessment
Track the patient's main activity limitation and symptom response, using consistent examination methods. Review after an agreed finite trial. Repeated tenderness without functional improvement should prompt reconsideration, not automatic escalation.
Safety and Further Education
Stop for electric-shock sensations, new numbness or unexpected pain. Read contraindications and precautions and explore treatment-planning education.
Regional Pain Relief*
Common Empirically-Tested Clinical Use
Overview
Regional pain relief describes an objective, not a diagnosis. This category concerns selected assessed musculoskeletal presentations. It does not cover every painful shoulder, back or limb, and it must not be confused with complex regional pain syndrome.
Anatomy and Treatment Targeting
Define the symptomatic region and the likely contributing tissues through appropriate assessment. Screen for referred, neurological and systemic causes. A pain map alone does not establish a safe treatment field.
Illustrative Protocol Framework
Reference 10 is the source for its specific trial protocol. Extract the device and applicator, anatomical field, pressure, pulses, Hz, treatment frequency, course length and exercise programme from the full methods. No regional-pain dose is proposed across diagnoses.
Technique and Care Integration
Use a comfortable supported position and coupling consistent with device instructions. Connect treatment with relevant activity, rehabilitation and self-management. The operator must recognise red flags and avoid giving a pain-relief intervention priority over necessary investigation.
Course of Care and Reassessment
Track pain interference, relevant disability measures and an activity goal. Establish an early review point. Refer progressive neurological deficit, unexplained systemic symptoms or worsening pain; bowel or bladder disturbance with saddle sensory change requires urgent assessment.
Safety and Further Education
Review the full safety resource and professional training catalogue.
Neuromuscular Dysfunction***
Experimental Indication
Overview
“Neuromuscular dysfunction” is too broad to identify one diagnosis or treatment. Weakness, altered coordination, abnormal tone and sensory symptoms require separate assessment. Evidence for spasticity cannot establish treatment of an unrelated neuromuscular disease.
Anatomy and Treatment Targeting
Symptoms may involve peripheral nerves, neuromuscular junctions, muscle or the central nervous system. A qualified clinician must determine the level and cause of dysfunction. External muscle tenderness does not identify a neurological lesion.
Illustrative Protocol Framework
No general clinical protocol is proposed. Device, applicator, energy, impulses, Hz and scheduling require a defined diagnosis and relevant human study. Animal exposure settings must not be transferred directly to a massage or wellness service.
Technique and Care Integration
Prioritise neurological assessment and diagnosis-specific rehabilitation. Any investigational intervention belongs within an appropriate specialist or research pathway, with device-specific training, consent and monitoring. Routine massage positioning and coupling guidance cannot establish a neurological treatment technique.
Course of Care and Reassessment
Use diagnosis-specific strength, function and participation measures under the treating team's direction. Research should define review timing and stopping criteria prospectively. New weakness, gait deterioration, swallowing problems or respiratory symptoms warrant prompt medical assessment.
Safety and Further Education
Review shockwave precautions and professional education. Education does not establish efficacy for an experimental use.
Safety and Contraindications in Massage-Related Practice
Begin with a documented assessment, a clear objective and a review of the device instructions. Screen relevant medical history, medication use, skin condition, sensation, bleeding risk, recent surgery and implanted devices. Clinical screening considerations are not all absolute contraindications and should be assessed individually.
ISMST distinguishes radial and low-energy focused applications from high-energy focused treatment. It identifies tumour, fetal exposure and implanted cardiac devices within the treatment field, with additional high-energy restrictions including lung/CNS exposure and significant coagulation disorders.[1] Consult the full guidance and device instructions; this summary is not a complete screening checklist.
Obtain consent covering alternatives, uncertain benefit, expected costs and possible discomfort, redness or bruising. Orthopaedic trial findings cannot establish safety for every body region or neurological condition.[2] Monitor skin and symptoms during and after treatment, particularly where sensation is altered. Never instruct a patient to stop prescribed medication without the prescriber's involvement.
Stop for unexpected severe pain, new sensory or motor change, significant bruising or skin injury. Refer suspected acute neurological disease, thrombosis, infection or other serious pathology for appropriate assessment. Calling an application elective does not change these responsibilities.
Build Better Clinical Reasoning for Complementary Care
Explore shockwave adjuncts to manual therapy through Wasabi Method's professional education. Learn how to evaluate device principles, research methods, anatomical targets, treatment planning, outcome tracking and referral decisions.
The online course catalogue is intended for eligible professionals seeking evidence-informed learning. Check each course's audience, prerequisites and practical requirements. Confirm separately whether a proposed application is permitted within your own professional role.
Medical Education Disclaimer
This material provides professional education and is not an individual diagnosis or treatment prescription. Protocol summaries describe research and are incomplete without the original methods and device instructions. Decisions require individual assessment, appropriate qualifications, professional judgment and compliance with applicable regulations and scope of practice. Findings from one device, population or treatment setting cannot automatically be generalised to another. Experimental applications require clear disclosure of uncertainty and appropriate clinical or research oversight.
References
- International Society for Medical Shockwave Treatment. ISMST recommendations: consensus statement on ESWT indications and contraindications; terms and definitions. Indications statement headed October 12, 2016; terminology statement dated June 20, 2017. Accessed October 18, 2026. https://shockwavetherapy.org/ismst-recommendations/
- Schmitz C, Császár NBM, Milz S, et al. Efficacy and safety of extracorporeal shock wave therapy for orthopedic conditions: a systematic review on studies listed in the PEDro database. Br Med Bull. 2015;116(1):115-138. doi:10.1093/bmb/ldv047. https://doi.org/10.1093/bmb/ldv047
- Otero-Luis I, Cavero-Redondo I, Álvarez-Bueno C, et al. Effectiveness of extracorporeal shock wave therapy in treatment of spasticity of different aetiologies: a systematic review and meta-analysis. J Clin Med. 2024;13(5):1323. doi:10.3390/jcm13051323. https://doi.org/10.3390/jcm13051323
- Ji HM, Kim HJ, Han SJ. Extracorporeal shock wave therapy in myofascial pain syndrome of upper trapezius. Ann Rehabil Med. 2012;36(5):675-680. doi:10.5535/arm.2012.36.5.675. https://doi.org/10.5535/arm.2012.36.5.675
- Ke MJ, Chen LC, Chou YC, et al. The dose-dependent efficiency of radial shock wave therapy for patients with carpal tunnel syndrome: a prospective, randomized, single-blind, placebo-controlled trial. Sci Rep. 2016;6:38344. doi:10.1038/srep38344. https://doi.org/10.1038/srep38344
- Yang L, Li X, Li S, Yang J, Meng D. Effect of extracorporeal shock wave therapy on nerve conduction: a systematic review and meta-analysis. Front Neurol. 2024;15:1493692. doi:10.3389/fneur.2024.1493692. https://doi.org/10.3389/fneur.2024.1493692
- Sanzo P, Agostino M, Fidler W, et al. Shockwave therapy and fibromyalgia and its effect on pain, blood markers, imaging, and participant experience - a multidisciplinary randomized controlled trial. Physiother Theory Pract. 2025;41(1):99-114. doi:10.1080/09593985.2024.2321503. https://doi.org/10.1080/09593985.2024.2321503
- Yu H, Chen G, Enayirilla P, et al. The efficacy of extracorporeal shock wave therapy for temporomandibular joint disorders: a meta-analysis. J Oral Rehabil. 2026;53(10):1823-1835. doi:10.1111/joor.70233. https://doi.org/10.1111/joor.70233
- Fleckenstein J, Friton M, Himmelreich H, Banzer W. Effect of a single administration of focused extracorporeal shock wave in the relief of delayed-onset muscle soreness: results of a partially blinded randomized controlled trial. Arch Phys Med Rehabil. 2017;98(5):923-930. doi:10.1016/j.apmr.2016.11.013. https://doi.org/10.1016/j.apmr.2016.11.013
- Walewicz K, Taradaj J, Rajfur K, et al. The effectiveness of radial extracorporeal shock wave therapy in patients with chronic low back pain: a prospective, randomized, single-blinded pilot study. Clin Interv Aging. 2019;14:1859-1869. doi:10.2147/CIA.S224001. https://doi.org/10.2147/CIA.S224001
- Kenmoku T, Ochiai N, Ohtori S, et al. Degeneration and recovery of the neuromuscular junction after application of extracorporeal shock wave therapy. J Orthop Res. 2012;30(10):1660-1665. doi:10.1002/jor.22111. https://doi.org/10.1002/jor.22111
Editorial Information
Author: Wasabi Method | SWSNA
Medical reviewer: Adam Gavine, BHK, M.Chiro | Shockwave Trainer | International Medical Shockwave Advisor
Medical review date: 10/2026
Source-check date: October 18, 2026
Editorial approach: Manufacturer-neutral interpretation of clinical research. Explicit ISMST categories, editorial mappings, evidence certainty and professional permissions are distinguished throughout. Most cited studies concern medical or rehabilitation settings; they do not independently establish outcomes in massage-only practice.
Disclosures: Wasabi Method offers commercial shockwave education and markets related services or products. The named reviewer's stated roles include shockwave training and medical advisory work.
Wasabi Method | Clinical Knowledge. Practical Impact.
Wasabi Method provides professional shockwave education and clinical resources to support informed, collaborative care. Educational content does not extend a practitioner's licence, specialty or professional scope.
Explore shockwave training · Review shockwave safety and contraindications